Transient Suppression of Ligand-mediated Activation of Epidermal Growth Factor Receptor by Tumor Necrosis Factor-α through the TAK1-p38 Signaling Pathway*
暂无分享,去创建一个
Hiroaki Sakurai | H. Sakurai | I. Saiki | Y. Ueno | Shunsuke Suzuki | Shunsuke Suzuki | Ikuo Saiki | Mitsuhiro Matsuo | Pattama Singhirunnusorn | Yoko Ueno | M. Matsuo | Pattama Singhirunnusorn
[1] Y. Yarden,et al. Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[2] E. Peralta,et al. The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity , 1997, The EMBO journal.
[3] S. Winograd-Katz,et al. Cisplatin induces PKB/Akt activation and p38MAPK phosphorylation of the EGF receptor , 2006, Oncogene.
[4] J. Voorhees,et al. Epidermal growth factor receptor is a critical mediator of ultraviolet B irradiation-induced signal transduction in immortalized human keratinocyte HaCaT cells. , 2006, The American journal of pathology.
[5] H. Sakurai,et al. Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin αv‐mediated ADAM activity in hepatocellular carcinoma: A novel functional target for gefitinib , 2006, Cancer science.
[6] Xuejun Jiang,et al. Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain. , 2006, Molecular cell.
[7] E. Mekada,et al. A Dual Signaling Cascade That Regulates the Ectodomain Shedding of Heparin-binding Epidermal Growth Factor-like Growth Factor* , 2001, The Journal of Biological Chemistry.
[8] A. Motley,et al. Clathrin-mediated endocytosis in AP-2–depleted cells , 2003, The Journal of cell biology.
[9] Y. Yarden,et al. p38 MAP kinase mediates stress‐induced internalization of EGFR: implications for cancer chemotherapy , 2006, The EMBO journal.
[10] S. Akira,et al. Essential function for the kinase TAK1 in innate and adaptive immune responses , 2005, Nature Immunology.
[11] D. Lauffenburger,et al. The Response of Human Epithelial Cells to TNF Involves an Inducible Autocrine Cascade , 2006, Cell.
[12] A. Ullrich,et al. GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathways , 2005, Biological chemistry.
[13] S. Higashiyama,et al. ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk. , 2005, Biochimica et biophysica acta.
[14] H. Sakurai,et al. Critical Roles of Threonine 187 Phosphorylation in Cellular Stress-induced Rapid and Transient Activation of Transforming Growth Factor-β-activated Kinase 1 (TAK1) in a Signaling Complex Containing TAK1-binding Protein TAB1 and TAB2* , 2005, Journal of Biological Chemistry.
[15] J. Kartenbeck,et al. Stress kinase p38 mediates EGFR transactivation by hyperosmolar concentrations of sorbitol , 2002, Journal of cellular physiology.
[16] M. Karin,et al. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.
[17] K. Carraway,et al. Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage , 2000, Oncogene.
[18] Y. Yarden,et al. Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.
[19] G. Weskamp,et al. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands , 2004, The Journal of cell biology.
[20] S. Averbuch,et al. Gefitinib (‘Iressa’, ZD1839) and new epidermal growth factor receptor inhibitors , 2004, British Journal of Cancer.
[21] Y. Wan,et al. EGF receptor crosstalks with cytokine receptors leading to the activation of c-Jun kinase in response to UV irradiation in human keratinocytes. , 2001, Cellular signalling.
[22] G. Johnson,et al. Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases , 2002, Science.
[23] H. Sakurai,et al. Selective inhibition of TNF-α-induced activation of mitogen-activated protein kinases and metastatic activities by gefitinib , 2005, British Journal of Cancer.
[24] A. Ullrich,et al. EGFR signal transactivation in cancer cells. , 2003, Biochemical Society transactions.
[25] Richard C Zangar,et al. Induced Autocrine Signaling through the Epidermal Growth Factor Receptor Contributes to the Response of Mammary Epithelial Cells to Tumor Necrosis Factor α* , 2004, Journal of Biological Chemistry.
[26] A. Ullrich,et al. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors , 1996, Nature.
[27] E. Mekada,et al. ErbB and HB-EGF signaling in heart development and function. , 2006, Cell structure and function.
[28] Michael D. Schneider,et al. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function , 2006, Nature Immunology.
[29] M. Garcia-Lloret,et al. Epidermal growth factor inhibits cytokine‐induced apoptosis of primary human trophoblasts , 1996, Journal of cellular physiology.
[30] S. Tsai,et al. Distinctive activation patterns in constitutively active and gefitinib-sensitive EGFR mutants , 2006, Oncogene.
[31] S. Gabriel,et al. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.
[32] N. Hynes,et al. ErbB receptors: directing key signaling networks throughout life. , 2004, Annual review of pharmacology and toxicology.
[33] P. Dempsey,et al. ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors. , 2006, American journal of physiology. Cell physiology.
[34] John Mendelsohn,et al. The EGF receptor family as targets for cancer therapy , 2000, Oncogene.
[35] Lee M Ellis,et al. Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[36] G. Carpenter,et al. Epidermal growth factor, its receptor, and related proteins. , 1986, Experimental cell research.
[37] H. Sanjo,et al. The Journal of Experimental Medicine CORRESPONDENCE , 2005 .
[38] W. Gullick,et al. Mutations of the epidermal growth factor receptor in non-small cell lung cancer -- search and destroy. , 2006, European journal of cancer.
[39] D. Barlow,et al. Heparin-binding epidermal growth factor and its receptors mediate decidualization and potentiate survival of human endometrial stromal cells. , 2005, The Journal of clinical endocrinology and metabolism.
[40] J. Avruch,et al. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. , 2001, Physiological reviews.
[41] Robert J Coffey,et al. EGF receptor ligands. , 2003, Experimental cell research.
[42] G. Argast,et al. Epidermal Growth Factor Receptor Transactivation Mediates Tumor Necrosis Factor-induced Hepatocyte Replication* , 2004, Journal of Biological Chemistry.
[43] Michael Karin,et al. Ultraviolet Light and Osmotic Stress: Activation of the JNK Cascade Through Multiple Growth Factor and Cytokine Receptors , 1996, Science.
[44] R. Puertollano,et al. Activation of p38 Mitogen-Activated Protein Kinase Promotes Epidermal Growth Factor Receptor Internalization , 2006, Traffic.
[45] K. Irie,et al. TAK1 Mediates the Ceramide Signaling to Stress-activated Protein Kinase/c-Jun N-terminal Kinase* , 1997, The Journal of Biological Chemistry.
[46] Joseph Schlessinger,et al. Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.
[47] P. Jänne,et al. The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies. , 2006, Cancer cell.
[48] S. Anderson,et al. Inhibition of Src Family Kinases Blocks Epidermal Growth Factor (EGF)-induced Activation of Akt, Phosphorylation of c-Cbl, and Ubiquitination of the EGF Receptor* , 2002, The Journal of Biological Chemistry.
[49] H. Sakurai,et al. TAK1‐mediated stress signaling pathways are essential for TNF‐α‐promoted pulmonary metastasis of murine colon cancer cells , 2006, International journal of cancer.